Inhibiting KSHV replication by targeting the essential activities of KSHV processivity protein, PF‐8
Journal of Medical Virology · 2024-10 · 96 (10)
DOI: 10.1002/jmv.29958 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, online erschienen am 07.10.2024. Verfasst von Jennifer Kneas Travis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological and Biomedical Sciences, North Carolina Central University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Virus Replication, Viral Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kaposi's Sarcoma Herpesvirus (KSHV) is the causative agent of several human diseases. There are no cures for KSHV infection. KSHV establishes biphasic lifelong infections. During the lytic phase, new genomes are replicated by seven viral DNA replication proteins. The processivity factor's (PF‐8) functions to tether DNA polymerase to DNA, so new viral genomes are efficiently synthesized. PF‐8 self‐associates, interacts with KSHV DNA replication proteins and the viral DNA. Inhibition of viral DNA replication would diminish the infection within a host and reduce transmission to new individuals. In this review we summarize PF‐8 molecular and structural studies, detail the essential protein‐protein and nucleic acid interactions needed for efficient lytic DNA replication, identify future areas for investigation and propose PF‐8 as a promising antiviral target. Additionally, we discuss similarities that the processivity factor from Epstein‐Barr virus shares with PF‐8, which could promote a pan‐herpesvirus antiviral therapeutic targeting strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological and Biomedical Sciences, North Carolina Central University, Durham, North Carolina, USA.
- Integrated Biosciences (INBS) Doctoral Program, North Carolina Central University, Durham, North Carolina, USA.
ORCID-Profile: Lindsey M Costantini
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Travis, J. K., & Costantini, L. M. (2024). Inhibiting KSHV replication by targeting the essential activities of KSHV processivity protein, PF‐8. Journal of Medical Virology, 96(10). https://doi.org/10.1002/jmv.29958
Vancouver
Travis JK, Costantini LM. Inhibiting KSHV replication by targeting the essential activities of KSHV processivity protein, PF‐8. Journal of Medical Virology. 2024;96(10). doi:10.1002/jmv.29958
BibTeX
@article{Travis2024,
author = {Travis, Jennifer Kneas and Costantini, Lindsey M},
title = {Inhibiting KSHV replication by targeting the essential activities of KSHV processivity protein, PF‐8},
journal = {Journal of Medical Virology},
year = {2024},
volume = {96},
number = {10},
doi = {10.1002/jmv.29958}
}
EUVIMED